MDL | - |
---|---|
Molecular Weight | - |
Molecular Formula | Unspecified |
SMILES | - |
Fibronectin, a glycoprotein (~500 kDa) present in blood as well as in cells, is a biomarker of tissue injury. Fibronectin binds to membrane-spanning receptor proteins called integrins. Fibronectin also binds to other extracellular matrix proteins such as collagen, fibrin, and heparan sulfate proteoglycans [1] .
Fibronectin (FN) is a glycoprotein present in blood as well as in cells. While Fibronectin (FN) in blood has many functions, its primary role is to promote wound repair following injury. Increases in plasma Fibronectin (FN) has been reported after inflammation, trauma, and diseases such as atherosclerosis. Tobacco-related lung diseases are characterized by increased accumulation of Fibronectin (FN) which can be induced by nicotine. We found significant increases of plasma Fibronectin (FN) following exposure to e-cig aerosols and TS. Although our study examined the levels of 8-oxodG, CRP, and Fibronectin (FN), additional markers for lung injury need be explored in future studies
[1]
.
Fibronectin also binds to other extracellular matrix proteins such as collagen, fibrin, and heparan sulfate proteoglycans (e.g. syndecans)
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT02694198 | Ain Shams Maternity Hospital |
Medical; Abortion, Fetus
|
September 2015 | |
NCT00371046 | Thomas Jefferson University |
Preterm Birth
|
October 2003 | Not Applicable |
NCT02021539 | Centre Hospitalier Universitaire de N?mes |
Obstetric Labor|Labor Onset|Obstetric Labor, Premature
|
February 2014 | |
NCT05300152 | Suez Canal University |
Drug Effect
|
October 2022 | Not Applicable |
NCT01812239 | Obstetrix Medical Group|Mednax Center for Research, Education, Quality and Safety |
Premature Birth
|
March 2014 | Phase 2|Phase 3 |
NCT01431885 | University of California, San Francisco |
Preterm Labor|Preterm Delivery
|
August 2011 | Not Applicable |
NCT00156000 | Obstetrix Medical Group|Adeza Biomedical|Mednax Center for Research, Education, Quality and Safety |
Preterm Delivery|Preterm Birth
|
August 2005 |
Solid
Room temperature in continental US; may vary elsewhere.
Sealed storage, away from moisture and light
Powder | -80°C | 2 years |
---|---|---|
-20°C | 1 year |
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
H 2 O : 8.33 mg/mL (ultrasonic and adjust pH to 7 with NaOH)